“SILVAMP TB LAM” rapid urine tuberculosis test predicts mortality in patients hospitalized with human immunodeficiency virus in South Africa
Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89%...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
January 9, 2020
|
| In: |
Clinical infectious diseases
Year: 2020, Volume: 71, Issue: 8, Pages: 1973-1976 |
| ISSN: | 1537-6591 |
| DOI: | 10.1093/cid/ciaa024 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/cid/ciaa024
|
| Author Notes: | Bianca Sossen, Tobias Broger, Andrew D. Kerkhoff, Charlotte Schutz, Andre Trollip, Emmanuel Moreau, Samuel G. Schumacher, Rosie Burton, Amy Ward, Robert J. Wilkinson, David A. Barr, Mark P. Nicol, Claudia M. Denkinger, and Graeme Meintjes |
| Summary: | Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%. |
|---|---|
| Item Description: | Gesehen am 20.01.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1537-6591 |
| DOI: | 10.1093/cid/ciaa024 |